HOFB.F Stock Overview
Operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Hofseth BioCare ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 0.13 |
| 52 Week High | NOK 0.22 |
| 52 Week Low | NOK 0.13 |
| Beta | 0.34 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -83.55% |
| 5 Year Change | -86.19% |
| Change since IPO | -63.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| HOFB.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | -1.3% |
| 1Y | n/a | 19.8% | 30.7% |
Return vs Industry: Insufficient data to determine how HOFB.F performed against the US Biotechs industry.
Return vs Market: Insufficient data to determine how HOFB.F performed against the US Market.
Price Volatility
| HOFB.F volatility | |
|---|---|
| HOFB.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HOFB.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine HOFB.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 70 | Jon Odegard | www.hofsethbiocare.com |
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company’s products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 2000 and is headquartered in Ålesund, Norway.
Hofseth BioCare ASA Fundamentals Summary
| HOFB.F fundamental statistics | |
|---|---|
| Market cap | US$58.41m |
| Earnings (TTM) | -US$10.97m |
| Revenue (TTM) | US$20.82m |
2.5x
P/S Ratio-4.8x
P/E RatioIs HOFB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HOFB.F income statement (TTM) | |
|---|---|
| Revenue | NOK 230.08m |
| Cost of Revenue | NOK 171.57m |
| Gross Profit | NOK 58.51m |
| Other Expenses | NOK 179.69m |
| Earnings | -NOK 121.18m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 08, 2024
| Earnings per share (EPS) | -0.29 |
| Gross Margin | 25.43% |
| Net Profit Margin | -52.67% |
| Debt/Equity Ratio | 129.1% |
How did HOFB.F perform over the long term?
See historical performance and comparison